1. Home
  2. CCCC vs QNC Comparison

CCCC vs QNC Comparison

Compare CCCC & QNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$4.17

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

QNC

Quantum eMotion Corp. Common Shares

N/A

Current Price

$3.29

Market Cap

434.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CCCC
QNC
Founded
2015
2007
Country
United States
Canada
Employees
N/A
5
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
404.7M
434.7M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
CCCC
QNC
Price
$4.17
$3.29
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.20
N/A
AVG Volume (30 Days)
2.9M
751.2K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
16.45
N/A
EPS
N/A
N/A
Revenue
$35,947,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.02
N/A
52 Week Low
$1.36
$1.90
52 Week High
$4.60
$3.51

Technical Indicators

Market Signals
Indicator
CCCC
QNC
Relative Strength Index (RSI) 62.85 57.37
Support Level $2.13 $2.58
Resistance Level N/A N/A
Average True Range (ATR) 0.37 0.25
MACD 0.06 0.03
Stochastic Oscillator 70.09 75.94

Price Performance

Historical Comparison
CCCC
QNC

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

About QNC Quantum eMotion Corp. Common Shares

Quantum eMotion Inc is dedicated to developing of a new generation of quantum-safe encryption for the quantum computing age. It is a developer of a new generation of cryptographic solutions under the acquisition of licenses. It allows clients and partners to develop secure quantum-safe encryption that can protect anything from consumer and enterprise devices like mobile phones, computers, the Internet of Things, and networking equipment to demanding cloud-based applications, servers, and military devices.

Share on Social Networks: